Abasaglar KwikPen 100 U/ml, solution injectable

7680650690023 CH-65069 Injektionslösung
Abasaglar KwikPen 100 U/ml, solution injectable
Abasaglar KwikPen 100 U/ml, solution injectable
Abasaglar KwikPen 100 U/ml, solution injectable
1 / 3
google

Article details

Package size
5 x 3
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/09/2020
Summary of Product Characteristics
Français
30/09/2020
Summary of Product Characteristics
Italien
30/09/2020
Patient information leaflet
Allemand
14/09/2020
Patient information leaflet
Français
14/09/2020
Patient information leaflet
Italien
14/09/2020

Detailed composition

Substance Quantity Type Category
(N/A)
3.64 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.04 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 64.65
Specialties list
Yes
Generic
No
SL addition date: 01/09/2015

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
65069
Drug name
Abasaglar KwikPen, solution injectable
Galenic form
INLFP
ATC Code
A10AE04
Authorization status
Z
Dispensing category
B
First authorization
09/07/2015
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine

Package details

Description (FR)
ABASAGLAR 100 U/ml Kwikpen (U80) 5 ser pré 3 ml
Description (DE)
ABASAGLAR 100 E/ml KwikPen (U80) 5 Fertspr 3 ml
Market launch
09/07/2015
Narcotic (BTM)
No

Other package sizes (1)

ABASAGLAR sol inj 100 U/ml Kwikpen 5 ser pré 3 ml
5 x 3 ML
GTIN: 7680650690016
View